Brainomix, Nanoflex Robotics associate to create AI robotics platform for stroke


British medtech firm Brainomix and Switzerland-based distant robotic surgical firm Nanoflex Robotics introduced the receipt of £400,000 ($420,418) and CHF 400,000 ($443,700), respectively, to co-develop an AI-assisted magnetic navigation system for stroke-related robotic surgical instruments.

Innovate UK, the innovation company in the UK, and Innosuisse, Switzerland’s Innovation Company, awarded the funds. 

Brainomix, spun out of the College of Oxford, creates AI-enabled software program to assist in therapy decision-making for stroke, most cancers and lung fibrosis.

Nanoflex is a medical robotics firm specializing in the therapy of ischemic stroke. The corporate developed a comfortable robotics system that inserts guidewires and catheters into the mind. It says its tech can simplify and shorten process time whereas lowering dangers related to assessing the mind for interventional stroke therapy. 

By the partnership, beginning in 2024, the businesses will mix their applied sciences to create an AI-assisted navigation software for units, resembling catheters, as they transfer via the vascular system.

“The venture goals to leverage the facility of synthetic intelligence to reinforce Nanoflex Robotics’ cutting-edge magnetic robotic navigation system to be the primary system worldwide to allow distant thrombectomy, thus remodeling stroke therapy choices and serving to enhance outcomes for sufferers,” Dr. George Harston, chief medical and innovation officer at Brainomix, stated in a press release.


Earlier this 12 months, Brainomix acquired FDA clearance for its AI-enabled stroke software program Brainomix 360 e-ASPECTS, utilized in stroke sufferers to measure the extent of early ischemic modifications or a discount or restriction of blood stream within the mind.

In 2021, the corporate closed a £16 million ($16.8 million) Series B funding round.

Earlier this month, Nanoflex Robotics introduced it scored a second grant from the Swiss Innovation Company, bringing its whole grant funding this 12 months to CHF 2.9 million ($3.2 million)

In February, the corporate additionally acquired $12 million in funding in a spherical led by Ascend Capital Companions with participation from Kinled Holding Ltd and Mountain Labs AG.

Different corporations within the robotics healthcare area are California-based Mendaera, which garnered $24 million in Series A funding in August, and Diligent Robotics, which scored $25 million in funding final month to develop the attain of its ‘socially clever service robots.’  

About Author

Leave a Reply

Your email address will not be published. Required fields are marked *